Doctor Henri Lu
Brigham and Women's Hospital, Harvard Medical School, Boston (United States of America)
Member of:
/f/125658/7246x3240/f72d1f6fc5/esc-logo-lock-up-red-pos-rgb.png){kind=logo}
/f/125658/3386x1417/951de003e4/hfa-acronym-name-rgb.png)
Prevalent and incident anemia in PARAGON-HF
Event: ESC Congress 2024
Topic: Heart Failure with Preserved Ejection Fraction (HFpEF)
Session: Collateral damage in heart failure: comorbidities and their treatment
Race in heart failure: a pooled participant-level analysis of the global PARADIGM-HF and PARAGON-HF trials
Event: ESC Congress 2024
Topic: Epidemiology, Prognosis, Outcome
Session: Deeper phenotyping in heart failure: race- and sex-related differences
Visit-to-visit changes in heart rate in heart failure: a pooled participant-level analysis of the PARADIGM-HF and PARAGON-HF trials
Event: ESC Congress 2024
Topic: Pathophysiology and Mechanisms
Session: Optimisation of heart failure treatment
Effects of Sacubitril/Valsartan on all-cause hospitalizations in heart failure: participant-level pooled analysis of PARADIGM-HF and PARAGON-HF
Event: ESC Congress 2024
Topic: Treatment
Session: Drug therapy for heart failure: what is new?
Malnutrition indices and prognosis across the BMI range in patients with HFpEF: insights from the PARAGON-HF trial
Event: Heart Failure 2024
Topic: Heart Failure with Preserved Ejection Fraction (HFpEF)
Session: Chronic heart failure - pathophysiology and mechanisms 6
